Hemogenyx Historical Income Statement
HEMO Stock | 343.40 20.90 6.48% |
Historical analysis of Hemogenyx Pharmaceuticals income statement accounts such as Other Operating Expenses of 6.8 M or Total Operating Expenses of 6.8 M can show how well Hemogenyx Pharmaceuticals PLC performed in making a profits. Evaluating Hemogenyx Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Hemogenyx Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Hemogenyx Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hemogenyx Pharmaceuticals is a good buy for the upcoming year.
Hemogenyx |
About Hemogenyx Income Statement Analysis
Hemogenyx Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Hemogenyx Pharmaceuticals shareholders. The income statement also shows Hemogenyx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Hemogenyx Pharmaceuticals Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Hemogenyx Pharmaceuticals. It is also known as Hemogenyx Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most accounts from Hemogenyx Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Hemogenyx Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hemogenyx Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Hemogenyx Pharmaceuticals' Cost Of Revenue is comparatively stable compared to the past year. Minority Interest is likely to gain to 6,106 in 2024, despite the fact that EBIT is likely to grow to (6.1 M).
Hemogenyx Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Hemogenyx Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hemogenyx Pharmaceuticals income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 31.3K | 33.2K | 2.6M | 33.0 | 316.0K | 365.3K | |
Selling General Administrative | 429.1K | 623.8K | 1.4M | 942.4K | 4.9M | 5.2M | |
Other Operating Expenses | 1.7M | 2.2M | 2.8M | 5.5M | 6.5M | 6.8M | |
Operating Income | (1.7M) | (2.2M) | (2.7M) | 4.0M | (6.5M) | (6.1M) | |
Ebit | (1.5M) | (2.1M) | (2.5M) | (4.0M) | (6.4M) | (6.1M) | |
Ebitda | (1.4M) | (2.0M) | (2.4M) | (3.4M) | (5.7M) | (5.4M) | |
Total Operating Expenses | 1.2M | 1.9M | 2.5M | 2.9M | 6.5M | 6.8M | |
Income Before Tax | (1.5M) | (2.1M) | (5.1M) | (4.0M) | (6.7M) | (6.4M) | |
Net Income | (1.5M) | (2.1M) | (7.5M) | (4.3M) | (6.7M) | (6.4M) | |
Depreciation And Amortization | 94.7K | 106.8K | 126.3K | 564.1K | 645.7K | 678.0K | |
Selling And Marketing Expenses | 14.6K | 33.5K | 4.2K | 4.9M | 5.6M | 5.9M | |
Gross Profit | (421.8K) | (350.7K) | (283.6K) | (2.6M) | (645.7K) | (678.0K) | |
Total Other Income Expense Net | 196.0K | 55.4K | (2.4M) | 10.6K | (230.6K) | (242.2K) | |
Income Tax Expense | (35K) | 20.4K | 2.4M | 361.2K | (5.8K) | (5.5K) | |
Interest Income | 14.2K | 3.4K | 18.0K | 10.6K | 85.3K | 89.6K | |
Net Income From Continuing Ops | (1.5M) | (2.1M) | (5.1M) | (4.0M) | (6.7M) | (6.4M) | |
Research Development | 21.25 | 83.66 | 37.58 | 402.94 | 90.6K | 95.2K | |
Cost Of Revenue | 421.8K | 350.7K | 283.6K | 2.6M | 645.7K | 653.2K | |
Net Income Applicable To Common Shares | (1.5M) | (1.5M) | (2.1M) | (5.1M) | (4.6M) | (4.4M) | |
Net Interest Income | (17.1K) | (29.9K) | (2.6M) | 10.6K | (230.6K) | (242.2K) | |
Reconciled Depreciation | 94.7K | 106.8K | 126.3K | 195.2K | 645.7K | 678.0K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.